Anika Therapeutics, Inc. (ANIK)
9.505
-0.14
(-1.40%)
USD |
NASDAQ |
Dec 11, 16:00
9.505
0.00 (0.00%)
After-Hours: 16:43
Anika Therapeutics EPS Diluted (Quarterly): -0.1615 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Stryker Corp. | 2.221 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.175M |
| Revenue (Quarterly) | 27.82M |
| Total Expenses (Quarterly) | 30.99M |
| Enterprise Value | 105.54M |
| Gross Profit Margin (Quarterly) | 56.02% |
| Profit Margin (Quarterly) | -11.41% |
| Earnings Yield | -23.97% |
| Normalized Earnings Yield | -23.97 |